Jass Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 50.25%
- Profit Growth 39.52%
- Ebitda 64.45%
- Net Worth 31.67%
- Total Assets 21.06%
About Jass Life Sciences
Jass Life Sciences Private Limited (JLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2018 (Six years and eight months 14 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikram Ganganaboyana, Safia Begum, and Azeeza Khabir serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290TG2018PTC125104
- Company No.
125104
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Jass Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Ganganaboyana  | Director | 14-Jun-2018 | Current |
| Safia Begum | Director | 14-Jun-2018 | Current |
| Azeeza Khabir | Director | 01-Oct-2018 | Current |
Financial Performance of Jass Life Sciences.
Jass Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 50.25% increase. The company also saw a substantial improvement in profitability, with a 39.52% increase in profit. The company's net worth Soared by an impressive increase of 31.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jass Life Sciences?
Unlock access to Jass Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Agilesquad Solutions India Private LimitedVikram Ganganaboyana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jass Life Sciences?
Unlock and access historical data on people associated with Jass Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jass Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jass Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
